{
  "author": {
    "name": "Ilena Peng",
    "webUrl": "/author/profile/ilena-peng/",
    "description": "",
    "imageLarge": "https://secure.gravatar.com/avatar/f16d6fc2845f417ea0e93a3f2b6cd37d?s=136&d=mm&r=g",
    "estimate": 2,
    "social": [],
    "articles": [
      {
        "uri": "/2023/05/11/fda-panel-backs-approval-of-first-over-the-counter-birth-control-pill/",
        "title": "FDA panel backs approval of first over-the-counter birth control pill",
        "byline": "Ilena Peng and Madison Muller",
        "kicker": "News",
        "prettyDate": "May 11, 2023",
        "timeToRead": "4 minute",
        "image": {
          "uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2018/03/BirthControl.jpg",
          "width": "600",
          "height": "450"
        },
        "authors": [
          {
            "webUrl": "/author/profile/ilena-peng/",
            "name": "Ilena Peng"
          },
          {
            "webUrl": "/author/profile/madison-muller/",
            "name": "Madison Muller"
          }
        ],
        "kickerNode": [
          {
            "uri": "/news/",
            "sectionName": "News"
          }
        ],
        "summary": "Perrigo, which sought FDA approval for an over-the-counter version last summer after the Supreme Court's ruling that overturned Roe v. Wade, expects a final decision by the end of summer in the U.S.",
        "body": null
      },
      {
        "uri": "/2023/03/16/novo-nordisk-cuts-insulin-prices-following-move-by-eli-lilly/",
        "title": "Novo Nordisk cuts insulin prices, following move by Eli Lilly",
        "byline": "Ilena Peng and Emma Court",
        "kicker": "News",
        "prettyDate": "March 16, 2023",
        "timeToRead": "5 minute",
        "image": {
          "uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2020/02/InsulinSyringe.jpg",
          "width": "600",
          "height": "400"
        },
        "authors": [
          {
            "webUrl": "/author/profile/ilena-peng/",
            "name": "Ilena Peng"
          },
          {
            "webUrl": "/author/profile/emma-court/",
            "name": "Emma Court"
          }
        ],
        "kickerNode": [
          {
            "uri": "/news/",
            "sectionName": "News"
          }
        ],
        "summary": "Under mounting pressure, Novo Nordisk plans to cut list prices for insulin products by up to 75%, now the latest drugmaker to take such a step following a California lawsuit accusing drugmakers of driving up costs.",
        "body": null
      }
    ]
  }
}